Whether Wnt/β-catenin indeed lies downstream of HES6 in uveal melanoma cells and whether Wnt/β-catenin inhibitors prevent HES6 effects on proliferation and migration or MYC expression remain to be investigated. The gene discussed is MYC; the disease is uveal melanoma.